Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

Presence on the market after approval is just the second hurdle ... led by the gene therapy Zolgensma and the Cystic Fibrosis treatment Trikafta were the most successful launches according ...

Participants were randomly assigned to receive Trikafta or placebo based on age and weight: Aged 6 to < 12 years and less than 30 kg: morning dose of elexacaftor 100 mg/tezacaftor 50 mg/ivacaftor ...

Changing your hairstyle can do wonders for your self-esteem. Lithuanian hairstylist and founder of SelfStation, Jurgita ...

Alyftrek’s approval could also extend Vertex’s market exclusivity in cystic fibrosis, as the drug’s main U.S. patent expires in 2039, two years after Trikafta’s. Vertex priced the therapy at about ...

Toronto Maple Leafs defenseman Jake McCabe is learning to live with a few busted teeth. The 31-year-old took Lucas Raymond's stick to the face during Toronto's matchup on Dec. 27 against the Detroit ...

Lithocholic acid (LCA), a metabolite induced by calorie restriction (CR), activates AMPK and mimics anti-aging benefits. A ...

Calcipotriol-plus–5-FU therapy activates immune pathways, offering long-lasting protection against squamous cell carcinoma by ...

The FDA said there have been more than 8,000 "adverse effects" reported with dogs since the drug was released in May of 2023, ranging from incontinence to seizures and sometimes death.

People can't get over just how good she looks after surgery despite undergoing a handful of operations in one sitting ...

Coming off of Novo Nordisk's (NVO) sharp stock decline after its experimental weight ... patient benefit compared to the blockbuster drug Trikafta. Vertex has won two cystic fibrosis approvals ...

Late night TV has a new face, as comedian Taylor Tomlinson hosts the new show After Midnight on CBS. What is going to make After Midnight different from the other late-night offerings and who is going ...